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Abstract
Background
The purpose of the present study was to evaluate the relationship between chronic endome-
tritis and the epithelial-mesenchymal transition in the endometrium of infertile patients in the
implantation phase.
Methods
Endometrial biopsy specimens from 66 infertility patients were analyzed. The presence of
chronic endometritis was investigated by immunostaining for CD138. Immunohistochemical
staining for E-cadherin, N-cadherin, Slug, and Snail was performed, and the expression pro-
files were statistically analyzed according to the presence of chronic endometritis. When the
loss of E-cadherin expression and/or the positive expression of N-cadherin was detected,
the specimen was considered epithelial-mesenchymal transition-positive. Epithelial-mesen-
chymal transition-positive cases were also statistically analyzed according to the presence
of chronic endometritis. The characteristics of the patients in the epithelial-mesenchymal
transition-positive and epithelial-mesenchymal transition-negative groups were compared.
The association between variables, including age, body mass index, gravidity, parity, and
each causative factor of infertility and epithelial-mesenchymal transition positivity was
analyzed.
Results
The rates of the loss of E-cadherin expression, the gain of N-cadherin and epithelial-mesen-
chymal transition positivity were significantly higher in chronic endometritis patients. The
expression of Slug, cytoplasmic Snail, and nuclear Snail was also detected at significantly
higher rates in chronic endometritis patients. Chronic endometritis were related to the epi-
thelial-mesenchymal transition.
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Conclusion
The epithelial-mesenchymal transition was frequently detected in the endometrium in infer-
tile patients with chronic endometritis. Since the epithelial-mesenchymal transition is associ-
ated with chronic endometritis, the epithelial-mesenchymal transition appears to be involved
in the alteration of mechanisms of implantation.
Background
Chronic endometritis (CE) is a persistent chronic inflammatory process of the endome-
trium. CE is usually asymptomatic or presents with only subtle symptoms, including abnor-
mal uterine bleeding, dyspareunia, leucorrhea, and pelvic pain. It has not received much
attention, since it was thought that the diagnosis was of little significance [1–3]. However,
recent studies have focused on the association between CE and various gynecological condi-
tions, and have shown that CE has a positive relationship with infertility, implantation
failure and miscarriage [4–8]. For these reasons, CE is more frequently diagnosed in infertile
patients in recent clinical practice. CE is diagnosed pathologically using collected endome-
trial tissue. It is diagnosed based on pathological findings such as premature decidualization,
developmental differences between the gland and stroma, and the infiltration of plasma cells
that do not appear in the normal, non-CE, endometrial stromal area [1, 9]. However, at pres-
ent, there is no global diagnostic standard for CE based on clinical data, such as the implanta-
tion rate, and it is mainly diagnosed based on the presence of plasma cells in the endometrial
stroma. It has been reported that immunostaining of CD138 (syndecan-1) reveals the pres-
ence of plasma cells and is a useful method for the diagnosis of CE [10, 11]. CE is diagnosed
in this way based on the presence of plasma cells, which is considered to be a symbol of
chronic inflammation. However, the mechanism of impaired implantation related to chronic
inflammation has not yet been completely clarified, although the abnormal distribution of
immunocompetent cells and the modification of decidualization have been reported in the
endometrium with CE [11–14].
The epithelial-mesenchymal transition (EMT) is a process by which polarized epithelial
cells lose polarity and intercellular contraction and acquire mesenchymal cell motility [15]. It
is well known that the EMT plays crucial roles not only in normal embryological development,
but also in several pathological conditions such as wound healing, fibrosis, and cancer develop-
ment [16–19]. Focusing on the endometrium during the implantation phase, the mesenchy-
mal-epithelial transition (MET), which is the reverse process to the EMT, is induced in the
endometrium and promotes the acceptance of embryos to the uterus [20, 21]. The EMT also
plays an important role in implantation [22, 23]. On the other hand, the appearance of the
EMT is closely related to the presence of inflammation. However, to date, no studies have eval-
uated the status of the endometrial EMT in the implantation phase in humans, although the
identification of microRNA and Progesterone Receptor-regulated genes associated with the
EMT in the window of implantation have already been reported [24].
Thus, the occurrence of the EMT with or without CE was analyzed in infertile patients to
elucidate the pathophysiology of CE that causes impaired implantation. In addition, the effect
of the EMT on infertility was evaluated by examining the cause(s) of infertility that were asso-
ciated with the occurrence of the EMT in the endometrium.
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This study conformed to the Clinical Research Guideline of Shiga University of Medical Sci-
ence and was approved by the research ethics committee (IRB ethics committee approval
number, R2014-090). Written, informed consent to participate in this study was obtained
from all patients.
Patients and endometrial sampling
Infertile patients referred to the Department of Obstetrics and Gynecology of Shiga University
of Medical Science from April 2015 to March 2018 were enrolled.
Only patients who received in vitro fertilization (IVF) were selected for this study. At our
institute, hysteroscopy has been performed, in principle, to detect abnormal findings in the
uterine cavity, such as morphological abnormalities, submucosal myoma and endometrial
polyp before embryo transfer. Endometrial tissue sampling was performed for patients who
desired endometrial scratching, and/or an examination for the presence of CE. At the men-
strual cycle of the test, the patients were contraceptive.
Patients suffering from endocrine and autoimmune diseases, uterine malformation (e.g.,
septate uterus), submucous myoma, endometrial polyp detected by hysteroscopy, hydrosal-
pinx detected by ultrasonography or adenomyosis with over a uterine wall thickness of>2.5
cm at the time that hysteroscopy was performed for the diagnosis of CE were excluded from
this study [25–29]. Patients who had received�7 days of antibiotics for the treatment of CE
were also excluded [4].
The patients underwent a urine LH test provided by our hospital every day for three to four
days prior to the estimated ovulation day. On the day that the urine test became positive or the
following day, they visited our hospital and the growth status of the follicle was examined. If
the growth of the follicle was sufficient as a preovulatory follicle, the date of ovulation was esti-
mated and the patient was scheduled to undergo hysteroscopy and curettage at 7–9 days after
ovulation. On the day of endometrial sampling, the patient’s blood was sampled to measure
serum levels of estradiol (E2) and progesterone (P4). Patients with E2 <50 pg/mL and P4<8
ng/mL were excluded. Endometrial tissue obtained by the first curettage from each patient was
used in this study. The biopsy specimens were immediately fixed in 10% buffered formalin.
Clinical information, including age, gravidity, parity, body mass index (BMI), serum levels
of E2 and P4, and the cause of infertility were obtained from the clinical records. The diagnosis
of male factor, ovarian factor, immune factor and fertilization failure were made by the general
methods [30, 31]. The diagnosis of male factor was made as a cause of infertility based on a
semen analysis and judged based on the criteria of the WHO Manual, 5th edition [32]. The
patient was diagnosed with ovarian factor when the patient suffered from ovulatory dysfunc-
tion and premature ovarian insufficiency, as described by Farquhar et al. [33]. When sperm
immobilizing antibodies were detected in the patient’s serum, the patient was diagnosed with
immune factor as a cause of infertility [34]. Fertilization failure was diagnosed when the failure
of fertilization occurred in all oocytes [35]. In the present study, endometriosis was diagnosed
when the existence of endometrioma was confirmed by MRI or endometriosis was confirmed
and/or treated by laparotomy or laparoscopy within 3 years before participation in this study.
In addition, the tubal factor was determined when abnormalities such as obstruction, lift-up
and peri-fimbria adhesion were suspected on hysterosalpingography (HSG) and when fallo-
pian tube abnormality was observed on laparoscopy. In the present study, the diagnosis of
unexplained infertility was made when the above diagnosis was ruled out [36].
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Immunohistochemistry
Formalin-fixed, paraffin-embedded tissue blocks of the biopsied specimens were cut into 3-
μm-thick sections, deparaffinized, and rehydrated. Each section was used for immunostaining.
Immunohistochemical analyses were performed using an autostainer (Benchmark XT system;
Roche Diagnostics, Basel, Switzerland) according to the manufacturer’s instructions. The
primary antibodies used in this study were as follows: mouse monoclonal antibody against
CD138 (clone B-A38, 1:100, Cell Marque, CA, USA); mouse monoclonal antibody against E-
cadherin (clone 36, pre-diluted, Roche Diagnostics); mouse monoclonal antibody against N-
cadherin (clone 6G11, 1:25, DAKO Japan Co. Ltd., Kyoto, Japan); rabbit polyclonal antibody
against Slug (ab38551, 1:500, Abcam, Cambridge, UK); and rabbit polyclonal antibody against
Snail (ab180714, 1:100, Abcam). I-VIEW DAB universal kit (cat-no. 518100032) was used as a
detection system.
Negative controls consisted of slides run with an unspecific mouse IgG (I-2000-1, Vector
Laboratories, CA, USA) or unspecific rabbit IgG (I-1000-5, Vector Laboratories).
Analyses of immunostaining
In this study, diagnosis of CE was performed by pathologist using the immunostaining for
CD138. According to previous reports, the number of CD138-positive plasma cells under
high-power fields (magnification, ×400) was counted in 10 non-overlapping, random endome-
trial stromal areas. CE was diagnosed when one or more CD138-positive plasma cells were
detected by a pathologist in the endometrial stroma [8, 14].
All fields of each specimen were analyzed for detecting all markers. Membranous immuno-
reactivity for E- and N-cadherin was evaluated as positive staining. In the present study, when
one or more cell clusters were not stained with E-cadherin in the endometrial glands, it was
considered a loss of E-cadherin, because normal endometrial glands diffusely expressed E-cad-
herin. Similarly, the partial expression of N-cadherin was defined as a gain of N-cadherin
expression in the present study, because the diffuse expression of N-cadherin was not observed
in the present study. We defined a loss of E-cadherin expression or a gain of N-cadherin
expression based on presence of the abovementioned changes in more than one gland.
Nuclear immunoreactivity for Slug was evaluated as positive staining, and positive staining
in the endometrial glandular cells and stromal cells was analyzed separately. Moreover, nuclear
or cytoplasmic immunoreactivity for Snail was evaluated as positive staining, and were ana-
lyzed separately.
Power analysis
We calculated the number of patients required for enrollment using a software program pro-
vided by the Department of Biostatistics, Vanderbilt University (http://biostat.mc.vanderbilt.
edu/wiki/Main/PowerSampleSize). No studies have statistically compared the incidence of
EMT in CE. In addition, since no similar study has yet been published, the number of cases
was examined based on the results of studies examining the live birth rates of the cured CE
group and the persistent CE group after the treatment of CE. According to the results of this
study, the birth rate of IVF after treatment was 61% and 13% [4]. We selected the following set-
tings to determine the appropriate sample size in the “Dichotomous” section: “independent”,
“case-control”, “two proportion”, and “Fisher’s exact test”. We selected 0.05 for α and 0.8 for
power. We also selected 0.39 (1–0.61) for P0 (the probability of the outcome for a control
patient in prospective studies), and 0.87 (1–0.13) for P1 (the probability of the outcome in an
experimental subject in prospective studies), as we assumed that those who had an EMT
abnormality would not achieve a live birth. When we chose 1 for the ratio of control to
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experimental subjects for independent prospective studies, the calculation resulted in sample
sizes of 19 cases for the control group and 19 cases for the CE group. Thus, the numbers of sub-
jects in the present study were considered adequate.
Statistical analysis
Statistical analysis was performed using the Graph Pad Prism 5 software program (GraphPad
Software Inc., La Jolla, CA). The normality of distribution in each dataset was checked using
the Kolmogorov-Smirnov test, and Student’s t-test or the non-parametric Mann-Whitney U
test was used to test for significance depending on the distribution pattern. The significance of
differences in the loss of E-cadherin expression, the expression of N-cadherin, the loss of E-
cadherin expression and/or N-cadherin expression, the expression of stromal Slug, the expres-
sion of cytoplasmic Snail, the expression of nuclear Snail, and the expression of both stromal
Slug and cytoplasmic Snail was compared between the CE-positive group and CE-negative
group using a Fisher analysis.
When the loss of E-cadherin expression and/or the gain of N-cadherin expression was
detected, the specimen was designated EMT-positive. The patients’ characteristics, including
age, gravidity, parity, BMI, E2 and P4 levels, cause of infertility, and CE were compared
between the EMT-positive and EMT-negative groups.
In addition, since this was a retrospective study, a multivariate logistic regression analysis
was performed for 8 explanatory variables, including 7 infertility factors (male factor, tubal fac-
tor, endometriosis, ovarian factor, fertilization failure, immune factor and unexplained infer-
tility) and CE or EMT-positive with respect to the objective variable EMT-positive. SSPS
statistics (version 25) was used for this analysis. Odds ratios and P values were calculated. P
values of<0.05 were considered to indicate statistical significance in all analyses.
Results
A total of 97 infertility patients who agreed to participate in the study at this time were
included in the study. Out of these, 8 patients with endocrine and autoimmune diseases, 2
patients with uterine malformation, 3 patients with hydrosalpinx, 2 patients with submucous
myoma, 1 patient with adenomyosis (the patients also suffered from endometrial polyp) and 7
patients with endometrial polyps were excluded. Eight patients were excluded because of usage
of antibiotics (Fig 1). As a result, 31 patients were excluded and 66 patients were included in
the present study.
CE was identified in 35 of 66 patients (53.0%). Age, gravidity, parity, BMI, and E2 and P4
levels did not differ between the CE and Non-CE groups (Table 1). Regarding causes of infer-
tility, among ovarian factor, tubal factor, endometriosis, male factor, fertilization failure,
immune factor, and unexplained fertility, the rate of ovarian factor was higher in the Non-CE
group (Table 1).
Comparison of the cadherin expression profiles between the CE and Non-
CE groups
Table 2 summarizes the results of the immunohistochemical analyses in the CE and Non-CE
groups. The loss of E-cadherin expression in the endometrial glands was observed in 12 of 35
and 2 of 31 cases in the CE and Non-CE groups, respectively (p = 0.0067) (Fig 2A and 2B). N-
cadherin-positive glandular cells were seen in 19 and 7 cases in the CE and Non-CE groups,
respectively (p = 0.012) (Fig 2C and 2D). The loss of E-cadherin expression and/or N-cadherin
expression was observed in 23 and 8 cases in the CE and Non-CE groups, respectively
PLOS ONE EMT in CE endometrium
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(p = 0.0015). There were no differences in any of the staining patterns between the CE-positive
and CE-negative groups when staining was observed.
Comparison of the EMT marker expression between the CE and Non-CE
groups
Table 3 summarizes the associations between CE and the expression profiles of Slug and Snail.
The expression of Slug in stromal cells was seen in 34 of 35 and 21 of 31 cases in the CE and
Non-CE groups, respectively (p = 0.0019) (Fig 2E and 2F). No cases showing the expression of
Slug in endometrial glandular cells were present in either group. The cytoplasmic expression
of Snail was noted in 28 and 11 cases in the CE and Non-CE groups, respectively (p = 0.004)
(Fig 2G and 2H), and the nuclear expression of Snail was seen in 6 and 0 cases, respectively
Fig 1. A total of 97 infertility patients who agreed to participate in the study at this time were included in the
study. Out of these, 8 patients with endocrine and autoimmune diseases, 2 patients with uterine malformation, 3
patients with hydrosalpinx, 2 patients with submucous myoma, 1 patient with adenomyosis and 7 patients with
endometrial polyps were excluded. Eight patients were excluded because of usage of antibiotics. As a result, 31 patients
were excluded and 66 patients were included in the present study. CE was identified in 35 of 66 patients.
https://doi.org/10.1371/journal.pone.0249775.g001
Table 1. Patient characteristics in the CE and Non-CE groups.
CE (35 cases) Non-CE (31 cases) p value
Age (years) 37.51 ± 0.66 36.39 ± 0.67 0.24
Gravity 0 (0–3) 0 (0–4) 0.97
Parity 0 (0–1) 0 (0–2) 1
Serum level of estradiol 115 (64–356) 111 (63–307) 0.53
Serum level of progesterone 14.7 ± 1.0 15.2 ± 1.2 0.75
Infertility cause
Ovarian factor 0 5 0.019
Tubal factor 9 10 0.6
Endometriosis 10 6 0.41
Male factor 6 9 0.38
Fertilization failure 3 1 0.62
Immune factor 0 0 1
Unexplained 12 5 0.16
CE, chronic endometritis.
Student’s t-test was performed, and the mean and standard error of the mean were shown when the distribution pattern was parametric. The Mann-Whitney U test was
used, and the median and minimum-maximum values were shown when the distribution pattern was non-parametric.
https://doi.org/10.1371/journal.pone.0249775.t001
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Table 2. The association between chronic endometritis and the cadherin expression profiles in the specimens.
CE (35 cases) Non-CE (31 cases) p value
Loss of E-cadherin 12 2 0.0068
Gain of N-cadherin 19 7 0.012
Loss of E-cadherin and/or gain of N-cadherin 23 8 0.0015
CE, chronic endometritis.
A Fisher analysis was used to compare the difference.
https://doi.org/10.1371/journal.pone.0249775.t002
Fig 2. Results of the immunohistochemical analysis of the specimens. (A) Endometrium diagnosed with chronic
endometritis. The infiltration of CD138-positive plasma cells was detected in the stromal area of the endometrium by
immunohistochemistry. (B) Endometrium diagnosed with non-chronic endometritis. No plasma cells were detected in
the stromal area of the endometrium by immunohistochemistry for CD138. (C) Endometrium without CD138
antibody staining. No staining was detected in the endometrium. (D) Endometrium without a loss of E-cadherin. The
expression of E-cadherin was detected in all the glandular cells in endometrial specimens. (E) Endometrium with a loss
of E-cadherin. A cluster of endometrial glandular cells without E-cadherin staining was observed (arrows). When such
a finding was detected, it was judged as a loss of E-cadherin. (F) Endometrium stained without E-cadherin antibodies.
No staining was detected in the endometrium. (G) Endometrium without N-cadherin expression. The expression of
N-cadherin was not detected in the glandular cells in endometrial specimens. (H) Endometrium with N-cadherin
expression. Gain of N-cadherin staining was present in part of the endometrial glandular cells. When positive staining
was observed, it was judged as a gain of N-cadherin expression. (I) Endometrium stained without N-cadherin
antibodies. No staining was detected in the endometrium. (J) Endometrium without the expression of Slug. Slug was
not expressed in the stromal cells of the endometrium. (K) Endometrium with the expression of Slug. Slug was
expressed in the nuclei of endometrial stromal cells. When positive staining was observed, it was judged as Slug-
positive. (L) Endometrium stained without Slug antibodies detected in the endometrium. (M) Endometrium without
expression of Snail. The expression of Snail was not noted in the glandular cells of the endometrium. (N)
Endometrium with the expression of Snail. The cytoplasmic expression of Snail was noted in the glandular cells of the
endometrium. When positive staining was observed, it was judged as Snail-positive. (O) Endometrium stained without
Slug antibodies. No staining was detected in the endometrium. Scale bar represents 50 μm.
https://doi.org/10.1371/journal.pone.0249775.g002
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(p = 0.026). The expression of both stromal Slug and cytoplasmic Snail was seen in 27 and 8
cases in the CE and Non-CE groups, respectively (p<0.0001). There were no differences in
any of the staining patterns between the CE-positive and CE-negative groups when staining
was observed.
The analysis of variables associated with EMT positivity
Table 4 summarizes the characteristics of the patients in the EMT-positive and EMT-negative
groups. Gravidity, parity, BMI, E2 and P4 levels did not differ between the EMT-positive and
EMT-negative groups; however, age tended to be higher in the EMT-positive group. Regarding
causes of infertility, among ovarian factor, tubal factor, endometriosis, male factor, fertilization
failure, anti-sperm antibody, unexplained fertility, and CE, only CE was higher in the EMT-
positive group; the other factors did not differ between the two groups.
Among the causes of infertility, CE was the only variable associated with EMT positivity in
the multivariate logistic analysis (p = 0.005, odds ratio 6.1, 95% CI 1.73–21.6).
Discussion
In the present study, according to previous reports, the number of CD138-positive plasma
cells under high-power fields (magnification, ×400) was counted in 10 non-overlapping,
Table 3. The associations between chronic endometritis and the expression of EMT markers in specimens.
CE (35 cases) Non-CE (31 cases) p value
Stromal Slug expression 34 21 0.0019
Cytoplasmic Snail expression 28 11 0.0004
Nuclear Snail expression 6 0 0.026
Both stromal Slug + Cyto Snail expression 27 8 <0.0001
CE, chronic endometritis; EMT, epithelial-mesenchymal transition.
A Fisher analysis was used to compare the difference.
https://doi.org/10.1371/journal.pone.0249775.t003
Table 4. Patient characteristics in the EMT-positive and EMT-negative groups.
EMT+ (31cases) EMT- (35 cases) p value
Age (years) 39 (28–44) 37 (27–43) 0.05
Gravity 0 (0–3) 0 (0–4) 0.63
Parity 0 (0–1) 0 (0–2) 0.91
Serum level of estradiol 114 (64–307) 118 (63–356) 0.7
Serum level of progesterone 14.9 ± 1.1 14.95 ± 1.1 0.99
Infertility cause
Ovarian factor 1 4 0.36
Tubal factor 6 13 0.17
Endometriosis 10 6 0.25
Male factor 5 10 0.26
Fertilization failure 1 3 0.62
Anti-sperm antibody 0 0 1
Unexplained fertility 11 6 0.1
Chronic endometritis 23 12 0.0015
EMT: epithelial-mesenchymal transition.
Student’s t-test was performed, and the mean and standard error of the mean were shown when the distribution pattern was parametric. The Mann-Whitney U test was
used, and the median and minimum-maximum values were shown when the distribution pattern was non-parametric.
https://doi.org/10.1371/journal.pone.0249775.t004
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random endometrial stromal areas. CE was diagnosed when one or more CD138-positive
plasma cells were detected by a pathologist in the endometrial stroma. The effect of CE on the
endometrial EMT in infertile patients was investigated according to this definition, and it was
found that the EMT occurred frequently in CE patients, and EMT-related transcription factor
was also frequently induced in CE patients.
Among the infertile cause of the patients, the risk factors for EMT were also investigated,
and it was found that CE was associated with an increased risk of the induction of the EMT.
Thus, CE was the only variable that was closely associated with the induction of the EMT in
the implantation-phase endometrium of infertile patients. To the best of our knowledge, this is
the first report on the impact of CE on the occurrence of the EMT in the endometrium.
One of the key functions of the endometrium is for embryos to implant and be nourished
for the establishment and maintenance of pregnancy. The process of embryo implantation has
long been classified into three phases: apposition, attachment, and penetration [37–39]. Appo-
sition is defined as unstable adhesion of the blastocyst to the endometrial surface, when blasto-
cysts and the endometrial apical surface face each other. During this stage, the trophoblasts
come close to the luminal epithelium. Then, trophoblasts begin to invade the endometrial sur-
face, in what is called the attachment phase. At this stage, the embryo and endometrium begin
cross-talk. A local increase in stromal vascular permeability at the blastocyst attachment site
occurs, and rapid morphological changes in the endometrium are initiated. Penetration is a
phase that involves the invasion of the embryo into the stromal area through the luminal epi-
thelium to establish a closer relationship with the mother. It has been reported that the EMT
and MET are involved at the time of this attachment or penetration [20, 22]. The transforma-
tion from EMT to MET does not occur in the normal endometrium; however, it is often seen
in other organs [40]. MET is thought to play a central role in the regeneration and decidualiza-
tion of the endometrium. However, EMT is only involved in the stage of embryo implantation
in the normal endometrium when stimulation from the embryo exists. If the EMT occurs in
the normal endometrium without an embryo at this stage, it is considered to be some kind of
irritation [41, 42].
This study examined the prevalence of the EMT was compared between the CE and non-
CE groups. As a result, CE might affect the increased EMT in the implantation-phase endome-
trium. This is the first article to show the frequent occurrence of EMT in the endometrium of
CE patients. This is therefore considered to be the strength of the present article.
On the other hand, these were limitations of the present study with respect to target, the
period of sample collection, method, and research items. 1) We did not perform laparoscopy
for all patients. Thus, endometriosis was not considered to be a cause of infertility in some of
the patients with early-stage endometriosis. In addition, a large number of patients with
implantation failure were potentially included in the patients treated with IVF [43, 44]. Since it
has been reported that CE is related to implantation failure [45, 46], and because we hypothe-
sized that the occurrence of EMT was related to implantation failure, IVF patients were tar-
geted in the present study. However, the occurrence of the EMT may differ from that in
patients who are not infertile. 2) This study examined the effect of CE on the non-physiological
EMT in the endometrium by limiting the phase of implantation. We did not examine the
occurrence of the EMT in other phases of the menstrual cycle, although this was because the
endometrial biopsy specimens could not be unnecessarily obtained from the patient multiple
times. 3) The presence of the EMT was determined by immunohistochemistry using tissue
samples obtained by endometrial biopsy. Recently, there have been reports that score the status
of the EMT according to RNA expression levels and/or next-generation sequencing [47–49].
Moreover, the presence of EMT was not scored; rather, the EMT was only evaluated by its
presence or absence in a tissue specimen [50]. 4) We focused on cadherin switch and the
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transcription factors involved in it, which is considered one of the most important steps of epi-
thelial to mesenchymal transition. We did not study the loss of epithelial markers such as
cytokeratin.
The EMT is induced via various signaling cascades, including the transforming growth fac-
tor-beta (TGF-β) pathway, a wide range of intracellular signaling pathways induced by TNF-α,
the Notch pathway, the Hedgehog pathway and the Wingless and INT-1 signaling pathway
[51, 52]. As CE represents a state of persistent inflammation, IL6, IL1β and TNFα are increased
during menstrual bleeding [53], and IL1βand TNFα is strongly expressed in the endometrial
tissue [54]. On the other hand, TGFβ1, which is associated with immune tolerance, is
increased in CE patients with moderate and severe intrauterine adhesion [55]. Both TNFα and
TGFβ have been shown to induce transcription factors such as Snail and Twist in immune
cells and cancer cells [56–59]. We hypothesize that these are representative mechanisms
related to the induction of the EMT in CE and that the EMT could be suppressed by the modu-
lation of these pathways. Furthermore, the EMT might be inhibited indirectly by suppressing
inflammation with immunosuppressants [60] and/or directly by EMT inhibitors, such as trani-
last [61, 62], which might improve clinical problems such as implantation failure and fibrosis
related to CE. We consider these to be subjects for future research.
Moreover, endometrial cancer and endometriosis, as well as CE, are known to be frequent in
infertile patients [4, 5, 9, 63–67]. Considering that CE is frequently found in infertile patients,
CE—by triggering the EMT—might be the cause of the increased prevalence of endometrial
cancer and endometriosis in infertile patients. The EMT is thought to be a central process of
cancer invasion and metastasis, and some recent studies have demonstrated an association
between endometriosis and the EMT [50, 68–70]. Moreover, regardless of the factors that
induce the EMT in stem cells (or non-stem cells), genetic or epigenetic changes caused by
endogenous or external stimuli establish a partial EMT and make the hybrid (epithelial-mesen-
chymal) phenotype stable [71, 72]. Whether the EMT or its reverse process, the MET, enables
cells to obtain pluripotency still remains controversial [73], it is necessary to study whether CE
affects the development of endometrial cancer or endometriosis through the EMT in the future.
Conclusion
This is the first report to demonstrate the association between CE and the endometrial EMT.
The infertility caused by CE may be due to the high frequency of the EMT in patients with CE
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